Search
Close this search box.
Search
Close this search box.
Search
Close this search box.

South Africa

GMAC Board Election Affirms Continuity, Drive toward Business for Good

Global org of leading business schools dedicated to advancing equitable access to education RESTON, Va., July 17, 2024 (GLOBE NEWSWIRE) — The Graduate Management Admission Council (GMAC), a non-profit association representing over 200 graduate business schools around the globe, today announced the election to her first full term of Itziar

Andan Foundation Announces Award for Innovation in Refugee Inclusion in Collaboration with the Massachusetts Institute of Technology’s MIT Solve

ZURICH, Switzerland, July 16, 2024 (GLOBE NEWSWIRE) — The Swiss-based humanitarian non-profit organisation, Andan Foundation, in collaboration with MIT Solve of the Massachusetts Institute of Technology (MIT), is delighted to announce this year’s Andan Prize for Innovation in Refugee Inclusion, which seeks to promote solutions that advance the economic, financial,

LS Retail and FreedomPay partner to deliver unified payments worldwide

Philadelphia, Pennsylvania, July 15, 2024 (GLOBE NEWSWIRE) — LS Retail, an Aptos Company has partnered with FreedomPay, the world’s largest independent payment gateway. This partnership enables retail and hospitality businesses that use LS Retail software to deliver simpler, faster payment experiences to their customers with minimum effort. LS Retail: Supporting

Minimum Deposit Casinos Announces Completion of Full Website Revamp

Before and After: MDC Website Redesign Comparison of the Minimum Deposit Casinos website before and after the comprehensive redesign. The updated site features streamlined navigation, enhanced functionality, a modern aesthetic, updated logo, and improved user-centric features. WATERFORD, Ireland, July 15, 2024 (GLOBE NEWSWIRE) — Minimum Deposit Casinos (MDC), a premier

CSL Behring Announces First Two Patients Treated with HEMGENIX® (etranacogene dezaparvovec) Gene Therapy for Hemophilia B in Europe

MARBURG, Germany, July 04, 2024 (GLOBE NEWSWIRE) — Global biotechnology leader CSL Behring (ASX: CSL) today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the first gene therapy administered as a treatment

RECENT NEWS

Copyright © 2024 Pakistan Press Release Point. All rights reserved.